15,19,23-trioxa-4,11-diaza-5,10(3,6)-dipyridazina-1,14(1,3)-dibenzenacyclotricosaphane-3,12-dione

ID: ALA5271248

Chembl Id: CHEMBL5271248

Max Phase: Preclinical

Molecular Formula: C34H38N6O5

Molecular Weight: 610.72

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1Cc2cccc(c2)OCCCOCCCOc2cccc(c2)CC(=O)Nc2ccc(nn2)CCCCc2ccc(nn2)N1

Standard InChI:  InChI=1S/C34H38N6O5/c41-33-23-25-7-3-11-29(21-25)44-19-5-17-43-18-6-20-45-30-12-4-8-26(22-30)24-34(42)36-32-16-14-28(38-40-32)10-2-1-9-27-13-15-31(35-33)39-37-27/h3-4,7-8,11-16,21-22H,1-2,5-6,9-10,17-20,23-24H2,(H,35,39,41)(H,36,40,42)

Standard InChI Key:  MUBLZKUWPDAGSB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5271248

    ---

Associated Targets(Human)

GLS Tchem Glutaminase kidney isoform, mitochondrial (16997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H358 (882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 610.72Molecular Weight (Monoisotopic): 610.2904AlogP: 4.76#Rotatable Bonds:
Polar Surface Area: 137.45Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.00CX Basic pKa: 3.19CX LogP: 3.67CX LogD: 3.67
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.29Np Likeness Score: 0.33

References

1. Lee EJ, Duggirala KB, Lee Y, Yun MR, Jang J, Cyriac R, Jung ME, Choi G, Chae CH, Cho BC, Lee K..  (2022)  Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysis.,  75  [PMID:36038117] [10.1016/j.bmcl.2022.128956]

Source